Patients Know Best Limited
06517382
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 20/11/2015
VENTURE CAPITALIST
CANADIAN · UNITED KINGDOM · Age 68
Also on 1 other board
director · Since 28/08/2025
SEGMENT DIRECTOR, DIGITAL HEALTH
BRITISH · NORWAY · Age 57
Persons with Significant Control
Former PSCs
Dr Mohammad Ahmed Yusuf Al-Ubaydli
Ceased 06/04/2016
Charges1 outstanding
GL 2024 LIMITED
HARBERT EUROPEAN SPECIALITY LENDING COMPANY S.A.R.L
CompanyRankvs 27915+ SIC 62012 peers41
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Net Worth
-£2.5M
Balance sheet strength
Cash
£2.4M
Cash in the bank
Profit Before Tax
-£1.9M
Bottom line earnings
Net Current Assets
-£802k
Working capital
Current Assets
£3.7M
Current Liabilities
£4.5M
Fixed Assets
£34k
Debtors
£1.3M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.82 | +£1.4M |
| 2022 | 0.40 | -£420k |
| 2021 | 0.57 | -£1.1M |
| 2020 | 0.82 | — |
Derived from filed accounts. Not audited figures.